Preferences for oral and injectable PrEP among qualitative sub-study participants in HPTN 084.

ABSTRACT:

Background

HPTN 084 compared the safety and efficacy of long-acting injectable cabotegravir (CAB) to daily oral TDF/FTC for prevention of HIV-1 in uninfected African women. Like a similar trial in MSM/TGW (HPTN 083), the trial was stopped early for efficacy, expediting the need to consider introduction strategies for different populations. We examine survey and qualitative data from a four-country sub-study to examine oral and injectable PrEP acceptability and considerations for CAB access among African women.

Methods

Participants completed baseline and follow-up surveys on HIV risk perception, sexual behavior. product acceptability and adherence during the blinded trial. Additionally, up to two in-depth interviews each with 73 sub-study participants explored product use and

SUBMITTER: Tolley EE 

PROVIDER: S-EPMC11498703 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature